112 related articles for article (PubMed ID: 9084808)
1. Shedding of HIV-1 in semen during primary infection.
Dyer JR; Gilliam BL; Eron JJ; Cohen MS; Fiscus SA; Vernazza PL
AIDS; 1997 Mar; 11(4):543-5. PubMed ID: 9084808
[No Abstract] [Full Text] [Related]
2. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
[TBL] [Abstract][Full Text] [Related]
3. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy.
Medeiros RP; Munerato P; Diaz RS
J Clin Virol; 2004 Aug; 30(4):346-7. PubMed ID: 15163426
[No Abstract] [Full Text] [Related]
5. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.
Sheth PM; Danesh A; Sheung A; Rebbapragada A; Shahabi K; Kovacs C; Halpenny R; Tilley D; Mazzulli T; MacDonald K; Kelvin D; Kaul R
J Infect Dis; 2006 Jan; 193(1):45-8. PubMed ID: 16323130
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.
Pereira AS; Kashuba AD; Fiscus SA; Hall JE; Tidwell RR; Troiani L; Dunn JA; Eron JJ; Cohen MS
J Infect Dis; 1999 Dec; 180(6):2039-43. PubMed ID: 10558966
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with changes in HIV shedding in semen.
Fiscus SA; Vernazza PL; Gilliam B; Dyer J; Eron JJ; Cohen MS
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S27-31. PubMed ID: 9581881
[TBL] [Abstract][Full Text] [Related]
8. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).
Eron JJ; Smeaton LM; Fiscus SA; Gulick RM; Currier JS; Lennox JL; D'Aquila RT; Rogers MD; Tung R; Murphy RL
J Infect Dis; 2000 May; 181(5):1622-8. PubMed ID: 10783117
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
[TBL] [Abstract][Full Text] [Related]
10. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
Khajotia RR; Feigley CE; Lee E; Gu J
AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
[No Abstract] [Full Text] [Related]
12. Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV.
Pasquier C; Bujan L; Daudin M; Righi L; Berges L; Thauvin L; Berrebi A; Massip P; Puel J; Izopet J
J Med Virol; 2003 Mar; 69(3):344-9. PubMed ID: 12526044
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
Simonelli C; Zanussi S; Comar M; Vaccher E; Giacca M; De Paoli P; Tirelli U
AIDS; 1998 Jan; 12(1):112-3. PubMed ID: 9456263
[No Abstract] [Full Text] [Related]
14. Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.
Gómez-Cano M; Soriano V; Pérez-Olmeda M; Machuca A; Rodríguez-Rosado R; Valencia E; Moreno V; Gutiérrez M; González-Lahoz J
AIDS; 1998 May; 12(8):964-6. PubMed ID: 9631158
[No Abstract] [Full Text] [Related]
15. Combined antiretroviral therapy is effective on blood plasma HIV-1-RNA: what about semen HIV-1-RNA levels?
Ghosn J; Chaix ML
AIDS; 2010 Jan; 24(2):309-11. PubMed ID: 19741480
[No Abstract] [Full Text] [Related]
16. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption.
Choudhury B; Pillay D; Taylor S; Cane PA
J Med Virol; 2002 Dec; 68(4):467-72. PubMed ID: 12376952
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.
Gupta P; Leroux C; Patterson BK; Kingsley L; Rinaldo C; Ding M; Chen Y; Kulka K; Buchanan W; McKeon B; Montelaro R
J Infect Dis; 2000 Jul; 182(1):79-87. PubMed ID: 10882584
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 in the female genital tract and the effect of antiretroviral therapy.
Cu Uvin S; Caliendo AM; Reinert SE; Mayer KH; Flanigan TP; Carpenter CC
AIDS; 1998 May; 12(7):826-7. PubMed ID: 9619822
[No Abstract] [Full Text] [Related]
20. [Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].
Reynes J; Montes B; Delmas B; Vendrell JP; Janbon F; Segondy M
Pathol Biol (Paris); 1997 May; 45(5):441-4. PubMed ID: 9296101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
